These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1239 related items for PubMed ID: 18096480

  • 1. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 2. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A.
    Transplantation; 2011 Jul 27; 92(2):217-23. PubMed ID: 21685829
    [Abstract] [Full Text] [Related]

  • 3. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P, Schmiedeskamp M, Neeley H, Oberholzer J, Benedetti E, Kaplan B.
    Transpl Infect Dis; 2008 Apr 27; 10(2):129-32. PubMed ID: 17605740
    [Abstract] [Full Text] [Related]

  • 4. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J, Casper K, Smallwood G, Stieber A, Fasola C, Lehneman J, Heffron T.
    Liver Transpl; 2007 Oct 27; 13(10):1396-400. PubMed ID: 17902124
    [Abstract] [Full Text] [Related]

  • 5. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2031-7. PubMed ID: 17161359
    [Abstract] [Full Text] [Related]

  • 6. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E, Kallas WM, Fishman JA.
    Clin Infect Dis; 2002 May 15; 34(10):1337-41. PubMed ID: 11981729
    [Abstract] [Full Text] [Related]

  • 7. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G.
    Clin Transplant; 1996 Dec 15; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, Salomón H, Videla C.
    J Clin Virol; 2004 Jul 15; 30(3):271-5. PubMed ID: 15135748
    [Abstract] [Full Text] [Related]

  • 9. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.
    J Med Virol; 2008 Oct 15; 80(10):1769-75. PubMed ID: 18712833
    [Abstract] [Full Text] [Related]

  • 10. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
    Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M.
    Lancet; 2000 Aug 19; 356(9230):645-9. PubMed ID: 10968438
    [Abstract] [Full Text] [Related]

  • 11. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.
    Transpl Infect Dis; 2011 Apr 19; 13(2):145-53. PubMed ID: 21070537
    [Abstract] [Full Text] [Related]

  • 12. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
    Gilbert C, LeBlanc MH, Boivin G.
    Herpes; 2001 Nov 19; 8(3):80-2. PubMed ID: 11867025
    [Abstract] [Full Text] [Related]

  • 13. Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
    Minces LR, Nguyen MH, Mitsani D, Shields RK, Kwak EJ, Silveira FP, Abdel-Massih R, Pilewski JM, Crespo MM, Bermudez C, Bhama JK, Toyoda Y, Clancy CJ.
    Antimicrob Agents Chemother; 2014 Nov 19; 58(1):128-35. PubMed ID: 24145525
    [Abstract] [Full Text] [Related]

  • 14. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, Bonvillain RW, Taylor DE, Dhillon GS.
    J Heart Lung Transplant; 2008 Aug 19; 27(8):875-81. PubMed ID: 18656801
    [Abstract] [Full Text] [Related]

  • 15. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K, Groll AH, Kuehn J, Vormoor J.
    Klin Padiatr; 2006 Aug 19; 218(3):180-4. PubMed ID: 16688677
    [Abstract] [Full Text] [Related]

  • 16. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
    Reusser P, Hostettler B, Attehbofer R.
    Schweiz Med Wochenschr; 1996 Oct 19; 126(42):1779-84. PubMed ID: 8966510
    [Abstract] [Full Text] [Related]

  • 17. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M, Burroughs AK, Sweny P, Hassan-Walker AF, Okwuadi S, Sabin C, Amooty G, Brown VS, Grace SC, Emery VC, Griffiths PD.
    J Infect Dis; 2004 Apr 15; 189(8):1355-61. PubMed ID: 15073671
    [Abstract] [Full Text] [Related]

  • 18. Is combination antiviral therapy for CMV superior to monotherapy?
    Drew WL.
    J Clin Virol; 2006 Apr 15; 35(4):485-8. PubMed ID: 16387546
    [Abstract] [Full Text] [Related]

  • 19. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM, Grinnan DC, Diane Reams B, Steele MP, Messier RH, Duane Davis R.
    Clin Transplant; 2004 Apr 15; 18(2):179-85. PubMed ID: 15016133
    [Abstract] [Full Text] [Related]

  • 20. [Strains of ganciclovir-resistant cytomegalovirus].
    Calicó I, García E, Cortés A, Gavaldá J, Roman A, Valle I.
    Enferm Infecc Microbiol Clin; 1999 Apr 15; 17(7):330-4. PubMed ID: 10535184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.